Comparison of rapid sensory characterization methodologies for the development of functional yogurts

Authors: Cadena, Rafael S., Caimi, Daniel, Jaunarena, Isabel, Lorenzo, Inés, Vidal, Leticia, Ares, Gastón, Deliza, Rosires, Giménez, Ana

Source: In Food Research International October 2014 64:446-455

Long-term (LT) disease control in patients (pts) with hormone receptor-positive (HR+), PIK3CA-altered advanced breast cancer (ABC) treated with alpelisib (ALP) + fulvestrant (FUL).

Authors: Juric, Dejan, Andre, Fabrice, Panwar, Udaiveer, Janku, Filip, Lu, Yen-Shen, Burris III, Howard A., Cruz Jurado, Josefina, Papai, Zsuzsanna, Stemmer, Salomon M., Tabernero, Josep, Ahlgren, Johan, Leheurteur, Marianne, Lorenzo, Ines, Jankovic, Dragana, Quadt, Cornelia, Hu, Huilin, Chen, Xueying, Rugo, Hope S.

Source: Journal of clinical oncology. 39(15 suppl):1054-1054

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173178907.0x000001&indx=1&recIds=ETOCvdc_100173178907.0x000001

PIK3CA mutation status, progression and survival in advanced HR + /HER2- breast cancer: a meta-analysis of published clinical trials.

Authors: Fillbrunn, Mirko, Signorovitch, James, André, Fabrice, Wang, Iris, Lorenzo, Ines, Ridolfi, Antonia, Park, Jinhee, Dua, Akanksha, Rugo, Hope S.

Source: BMC Cancer; 9/21/2022, Vol. 22 Issue 1, p1-11, 11p

Subject Terms: HORMONE receptor positive breast cancer, CLINICAL trial registries, EPIDERMAL growth factor receptors, METASTATIC breast cancer, BREAST cancer, CLINICAL trials, PHOSPHATIDYLINOSITOL 3-kinases

Patient-Reported Outcomes in Patients With -Mutated Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer From SOLAR-1.

Authors: Ciruelos, Eva Maria, Rugo, Hope S, Mayer, Ingrid A, Levy, Christelle, Forget, Frédéric, Delgado Mingorance, Juan Ignacio, Safra, Tamar, Masuda, Norikazu, Park, Yeon Hee, Juric, Dejan, Conte, Pierfranco, Campone, Mario, Loibl, Sibylle, Iwata, Hiroji, Zhou, Xiaolei, Park, Jinhee, Ridolfi, Antonia, Lorenzo, Ines, André, Fabrice

Source: Journal of Clinical Oncology; 6/20/2021, Vol. 39 Issue 18, p2005-2015, 11p

PO62 - THE ALPELISIB (ALP) EXPERIENCE IN THE SOLAR-1 AND BYLIEVE STUDIES: PERSPECTIVES FOR PRACTITIONERS CARING FOR PATIENTS (PTS) WITH HORMONE RECEPTOR-POSITIVE (HR+), HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HER2–) ADVANCED BREAST CANCER (ABC)

Authors: Rugo, Hope S., André, Fabrice, Park, Yeon Hee, Drullinsky, Pamela, Loibl, Sibylle, Cardoso, Fátima, Mason, Ginny, Aubel, Dawn, Lorenzo, Inés, Akdere, Murat, Ciruelos, Eva M.

Source: In The Breast October 2021 59 Supplement 1:S49-S49

This result is not displayed to guests.
Login for full access.